Comparative Study
doi: 10.1007/BF01963078.
Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin
Affiliations
- PMID: 3134211
- DOI: 10.1007/BF01963078
Item in Clipboard
Comparative Study
Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin
Eur J Clin Microbiol Infect Dis.
1988 Apr.
Abstract
A total of 585 Mycobacterium tuberculosis strains isolated during a three-year period in Sweden were tested for in vitro susceptibility to amikacin in comparison with streptomycin. Resistance to streptomycin was seen in 27 of the isolates (4.6%). These isolates had been obtained from 22 patients, a majority of which were non-European immigrants. All but one of the streptomycin-resistant isolates were susceptible to amikacin. None of 263 streptomycin-susceptible isolates tested was resistant to amikacin. Amikacin appears to be an alternative to streptomycin in the treatment of patients with streptomycin-resistant Mycobacterium tuberculosis.
Similar articles
-
Amikacin in the treatment of pulmonary tuberculosis.Tubercle. 1983 Jun;64(2):111-8. doi: 10.1016/0041-3879(83)90035-1. Tubercle. 1983. PMID: 6193623
-
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.Indian J Exp Biol. 2009 Jun;47(6):520-2. Indian J Exp Biol. 2009. PMID: 19634718
-
Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.Tubercle. 1982 Sep;63(3):201-8. doi: 10.1016/s0041-3879(82)80031-7. Tubercle. 1982. PMID: 6817487
-
In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.J Antimicrob Chemother. 1997 Jul;40(1):27-32. doi: 10.1093/jac/40.1.27. J Antimicrob Chemother. 1997. PMID: 9249201
-
Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.Antimicrob Agents Chemother. 1989 Aug;33(8):1298-301. doi: 10.1128/AAC.33.8.1298. Antimicrob Agents Chemother. 1989. PMID: 2478073 Free PMC article.
Cited by
-
Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau.J Clin Microbiol. 1993 Aug;31(8):2215-7. doi: 10.1128/jcm.31.8.2215-2217.1993. J Clin Microbiol. 1993. PMID: 8370754 Free PMC article.
-
Spread of drug-resistant pulmonary tuberculosis in Estonia.J Clin Microbiol. 2001 Sep;39(9):3339-45. doi: 10.1128/JCM.39.9.3339-3345.2001. J Clin Microbiol. 2001. PMID: 11526173 Free PMC article.
-
Use of aminoglycosides in treatment of infections due to intracellular bacteria.Antimicrob Agents Chemother. 2001 Nov;45(11):2977-86. doi: 10.1128/AAC.45.11.2977-2986.2001. Antimicrob Agents Chemother. 2001. PMID: 11600345 Free PMC article. Review. No abstract available.
-
Aminoglycoside therapy. Current use and future prospects.Pharm Weekbl Sci. 1990 Jun 22;12(3):81-90. doi: 10.1007/BF01967600. Pharm Weekbl Sci. 1990. PMID: 2196530 Review.
-
Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau.J Clin Microbiol. 1999 Dec;37(12):3872-8. doi: 10.1128/JCM.37.12.3872-3878.1999. J Clin Microbiol. 1999. PMID: 10565899 Free PMC article.